|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Wan, L., D. J. Battle, J. Yong, A. K. Gubitz, S. J. Kolb, J. Wang, and G. Dreyfuss. 2005. The survival of motor neurons protein determines the capacity for snRNP assembly: Biochemical deficiency in spinal muscular atrophy. Mol Cell Biol 25(13):5543–5551. Weisskopf, M., E. O’Reilly, H. Chen, M. Schwarzschild, and A. Ascherio. 2007. Plasma urate and risk of Parkinson’s disease. Am J Epidemiol 166(5):561–567. Winberg, M. 2007. Spinal muscular atrophy as a focus indication for biomarker development. Presentation at IOM Forum on Neuroscience and Nervous System Disorders workshop—Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships, Washington, DC, February 26–27. Wittchen, H. U., R. C. Kessler, H. Pfister, and M. Lieb. 2000. Why do people with anxiety disorders become depressed? A prospective-longitudinal community study. Acta Psychiatr Scand Suppl(406):14–23. World Health Organization. 2007. International classification of diseases, 10th revision. Geneva: World Health Organization. Yuan, P., S. Maeng, R. Schloesser, J. Maccammom, G. Chen, and H. K. Manji. 2007. Bcl-2 modulates behavioral responses to severe stress and the actions of antidepressants. Biol Psychiatry 61(8 Suppl):335.
|
|
|||||||||||||||
